Read about our work

Publications

• Role of the Pancreatic Islet Microvasculature in Health and Disease.

Aplin AC, Aghazadeh Y, Mohn OG, Hull-Meichle, RL: Role of the Pancreatic Islet Microvasculature in Health and Disease. J Histochem Cytochem 72:711-72810, 2024. 1369/00221554241299862

• Pancreas and islet morphology in cystic fibrosis: Clues to the etiology of cystic fibrosis-related diabetes.

Malik SS, Padmanabhan D, Hull-Meichle, RL: Pancreas and islet morphology in cystic fibrosis: Clues to the etiology of cystic fibrosis-related diabetes. Front Endocrinol 14:1269139, 2023. DOI 3389/fendo.2023.1269139

• Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings.

Mastracci TL, Apte M, Amundadottir LT, Alvarsson A, Artandi S, Bellin MD, Bernal-Mizrachi E, Caicedo A, Campbell-Thompson M, Cruz-Monserrate Z, El Ouaamari A, Gaulton KJ, Geisz A, Goodarzi MO, Hara M, Hull-Meichle RL, Kleger A, Klein AP, Kopp JL, Kulkarni RN, Muzumdar MD, Naren AP, Oakes SA, Olesen SS, Phelps EA, Powers AC, Stabler CL, Tirkes T, Whitcomb DC, Yadav D, Yong J, Zaghloul NA, Pandol SJ, Sander M: Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings. Diabetes. 2023 Apr 1;72(4):433-448 and 2022 Oct 1;51(9):1061-1073. DOI 10.2337/db22-0942

• Islet amyloid polypeptide aggregation exerts cytotoxic and proinflammatory effects on the islet vasculature in mice

Castillo JJ, Aplin AC, Hackney DJ, Hogan MF, Esser N, Templin AT, Akter R, Kahn SE, Raleigh DP, Zraika S, Hull RL. Islet amyloid polypeptide aggregation exerts cytotoxic and proinflammatory effects on the islet vasculature in mice. Diabetologia. 2022 Oct;65(10):1687-1700. DOI 1007/s00125-022-05756-9

• SGLT2-i improves markers of islet endothelial cell function in db/db diabetic mice

Hogan MF, Hackney DJ, Aplin AC, Mundinger TO, Larmore MJ, Castillo JJ, Esser N, Zraika S, Hull RL. SGLT2-i improves markers of islet endothelial cell function in db/db diabetic mice. J Endocrinol. 2021 Feb;248(2):95-106. doi: 10.1530/JOE-20-0354.

• Islet Interleukin-1β immunoreactivity is an early feature of cystic fibrosis that may contribute to β-cell failure

Hull RL, Gibson RL, McNamara S, Deutsch GH, Fligner CL, Frevert CW, Ramsey BW, Sanda S. Islet Interleukin-1β immunoreactivity is an early feature of cystic fibrosis that may contribute to β-cell failure. Diabetes Care. 2018 Apr;41(4):823-830. DOI 2337/dc17-1387